Chan Leslie W, Hern Kelsey E, Ngambenjawong Chayanon, Lee Katie, Kwon Ester J, Hung Deborah T, Bhatia Sangeeta N
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
ACS Infect Dis. 2021 Apr 9;7(4):721-732. doi: 10.1021/acsinfecdis.0c00805. Epub 2021 Mar 9.
The drug-impermeable bacterial membrane in Gram-negative pathogens limits antibiotic access to intracellular drug targets. To expand our rapidly waning antibiotic arsenal, one approach is to improve the intracellular delivery of drugs with historically poor accumulation in Gram-negative bacteria. To do so, we engineered macromolecular potentiators to permeabilize the Gram-negative membrane to facilitate drug influx. Potentiators, known as WD40, were synthesized by grafting multiple copies of a cationic α-helical antimicrobial peptide, WLBU2, onto a dextran polymer scaffold. WD40 enabled drug uptake in the model pathogen , a capability that was not observed with unmodified WLBU2 peptide. WD40 was able to reduce minimum inhibitory concentrations of a drug panel by up to 3 orders of magnitude. Hydrophobic and highly three-dimensional antibiotics exhibited the greatest potentiation. Antibiotic activity was potentiated in several clinical strains and resulted in sensitization of drug-resistant strains to rifampin, a drug not previously used for Gram-negative infections.
革兰氏阴性病原体中药物不可渗透的细菌膜限制了抗生素进入细胞内的药物靶点。为了扩充我们迅速减少的抗生素库,一种方法是改善在革兰氏阴性细菌中积累历来较差的药物的细胞内递送。为此,我们设计了大分子增效剂,使革兰氏阴性膜通透性增加以促进药物流入。被称为WD40的增效剂是通过将多个阳离子α-螺旋抗菌肽WLBU2拷贝接枝到葡聚糖聚合物支架上合成的。WD40能够使模型病原体摄取药物,而未修饰的WLBU2肽则没有这种能力。WD40能够将一组药物的最低抑菌浓度降低多达3个数量级。疏水性和高度三维的抗生素表现出最大的增效作用。在几种临床菌株中抗生素活性得到增强,并导致耐药菌株对利福平敏感,利福平是一种以前未用于革兰氏阴性感染的药物。